Misoprostol is a synthetic prostaglandin E1 analog that is initially used for the prevention of peptic and gastric ulcers and now an important drug for women's reproductive health. The main objective is to find out the efficacy and safety of misoprostol in the second trimester to reduce the inductionabortion interval considerably with the lowest possible posology and reduced adverse reactions. A total of 30 patients were enrolled for second trimester termination for various reasons including anomalous baby, contraceptive failures. All the subjects were received a single dose of misoprostol whose posology ranged from 400 to 2000µg intravaginally and was monitored to assess the outcome measures and side effects. Successful termination was possible to all the cases but induction to expulsion time varied from 4 to 21 hours and the maximum termination cases were between 14 and 16 hours (10 cases/ 33.3%). Only six subjects were experienced with side effects like fever, shivering, nausea, vomiting and diarrhea. As a conclusion, due to lesser side effects, non-surgical termination, lesser anxiety and reduced days of hospital stay, misoprostol at single drug is a safe, cost effective and high efficacious drug for second trimester termination.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.